HMGB1 released by ferroptotic cancer cells is a prototypical DAMP involved in the immunogenicity of cancer cells, and it triggers an inflammatory response in macrophages through binding to advanced glycosylation end-product-specific receptor (AGER/RAGE) (Wen et al., 2019). Here, HMGB1 is linked to cancer.